Yes also once FDA approves the trial the market will get a timeline this will change things. The approval will have the number of patients required and same for VIV. So most likely late Oct or November we will get approval after the animal study is finished.
I talked to a Dr about the triple VIV in May done in Sweden. He said it's basically impossible to do cause the patient has as high chance of paralysis and stroke. So the data shows we are superior to the current products this won't change plus it will save many people's lives.
1 to 2 years we will know where we stand and it will be good guys.
Video, page-17
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$9.10 |
Change
-0.810(8.17%) |
Mkt cap ! $192.3M | |||
| Open | High | Low | Value | Volume |
| $9.50 | $9.77 | $9.01 | $212.2K | 22.63K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 298 | $9.01 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $9.85 | 1000 | 1 |
View Market Depth
| Last trade - 16.10pm 13/11/2024 (20 minute delay) ? |
| AVR (ASX) Chart |